Haoxi Health Technology Limited Class A (HAO)
NASDAQ:HAO
Top Page
Haoxi Health Technology Limited Class A
(NASDAQ:HAO)
Select Model
Select Model
Rating:65Neutral
Price Target:
$1.50
▲(29.31% Upside)
Action:N/ADate:07/29/25
The overall score of 65 for HAO reflects a balanced but cautious outlook, driven primarily by mixed financial performance with strong growth and balance sheet stability offset by weak cash flows and margins. Valuation appears attractive with a low P/E ratio, while technical indicators suggest neutral momentum with a longer-term downtrend.
Positive Factors
Revenue Growth
Strong revenue growth indicates successful market penetration and product adoption, suggesting a robust demand for the company's offerings.
Negative Factors
Cash Flow Challenges
Negative operating cash flow indicates difficulties in generating cash from operations, which may hinder the company's ability to fund growth and meet obligations.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong revenue growth indicates successful market penetration and product adoption, suggesting a robust demand for the company's offerings.
Read all positive factors
Haoxi Health Technology Limited Class A (HAO) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$64.20M
Dividend YieldN/A
Average Volume (3M)970.53K
Price to Earnings (P/E)0.8
Beta (1Y)1.34
Revenue Growth-32.39%
EPS Growth41.48%
CountryUS
Employees30
SectorCommunication Services
Sector Strength97
IndustryAdvertising Agencies
Share Statistics
EPS (TTM)0.01
Shares Outstanding58,753,030
10 Day Avg. Volume34,415
30 Day Avg. Volume970,526
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.17
Price to Sales (P/S)0.09
P/FCF Ratio-0.90
Enterprise Value/Market Cap0.03
Enterprise Value/Revenue0.05
Enterprise Value/Gross Profit1.84
Enterprise Value/Ebitda0.40
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Haoxi Health Technology Limited Class A Business Overview & Revenue Model
Company Description
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customiz...
How the Company Makes Money
Haoxi Health Technology generates revenue through multiple streams, including the sale of medical devices and health monitoring systems directly to healthcare providers and institutions. Additionally, the company offers subscription-based services...
Haoxi Health Technology Limited Class A Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
40
Negative
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 32.80M | 48.52M | 28.23M | 16.16M | 12.85M |
| Gross Profit | 927.75K | 2.75M | 2.06M | 648.72K | 605.58K |
| EBITDA | 4.57M | 1.79M | 1.22M | 271.77K | 330.96K |
| Net Income | 3.88M | 1.29M | 969.75K | 244.59K | 304.06K |
Balance Sheet | |||||
| Total Assets | 21.60M | 15.51M | 4.46M | 542.99K | 2.81M |
| Cash, Cash Equivalents and Short-Term Investments | 8.62M | 6.66M | 1.20M | 293.51K | 55.89K |
| Total Debt | 1.99M | 1.20M | 850.06K | 505.40K | 335.03K |
| Total Liabilities | 4.22M | 4.23M | 2.90M | 2.01M | 4.74M |
| Stockholders Equity | 17.38M | 11.27M | 1.57M | -1.47M | -1.93M |
Cash Flow | |||||
| Free Cash Flow | -3.36M | -802.94K | -917.63K | -684.06K | 2.65M |
| Operating Cash Flow | -3.36M | -747.58K | -872.13K | -675.36K | 2.65M |
| Investing Cash Flow | -3.58M | -3.13M | -45.50K | -8.70K | -3.26K |
| Financing Cash Flow | 8.90M | 9.32M | 1.80M | 933.22K | -2.61M |
Haoxi Health Technology Limited Class A Technical Analysis
Negative
1.16
Price Trends
1.19
Negative
1.15
Negative
1.19
Negative
Market Momentum
-0.04
Positive
45.54
Neutral
23.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HAO, the sentiment is Negative. The current price of 1.16 is above the 20-day moving average (MA) of 1.14, below the 50-day MA of 1.19, and below the 200-day MA of 1.19, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 45.54 is Neutral, neither overbought nor oversold. The STOCH value of 23.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HAO.
Haoxi Health Technology Limited Class A Risk Analysis
Haoxi Health Technology Limited Class A disclosed 75 risk factors in its most recent earnings report. Haoxi Health Technology Limited Class A reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Haoxi Health Technology Limited Class A Peers Comparison
UnderperformOutperform
Sector (60)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $64.20M | 0.78 | 21.47% | ― | -32.39% | 41.48% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | $4.76M | 0.05 | 7.01% | ― | -5.65% | -41.43% | |
42 Neutral | $2.02M | -0.06 | ― | ― | -62.46% | -12.90% | |
41 Neutral | $2.20M | -2.04 | -50.26% | ― | -66.59% | 67.63% |
* Communication Services Sector Average
HAO
Haoxi Health Technology Limited Class A
1.08
-0.19
-14.96%
CNET
ZW Data Action Technologies
0.67
-0.84
-55.36%
CHR
Cheer Holding
2.31
-159.36
-98.57%
BAOS
Baosheng Media Group Holdings
2.68
0.21
8.54%
DRCT
Direct Digital Holdings
0.72
-25.91
-97.29%
STFS
Star Fashion Culture Holdings Ltd. Class A
4.03
-32.69
-89.03%
Haoxi Health Technology Limited Class A Corporate Events
Haoxi Health Technology Approves Major Shareholder Changes at December Meeting
Dec 10, 2025
On December 8, 2025, Haoxi Health Technology Limited held an extraordinary general meeting where shareholders approved several significant changes. These included increasing the voting rights of Class B shares from ten to thirty votes, expanding t...
Haoxi Health Technology Secures $5 Million in Private Placement
Dec 3, 2025
On November 26, 2025, Haoxi Health Technology Limited entered into a Securities Purchase Agreement with several non-U.S. investors for a private placement of 6,250,000 Class A ordinary shares and 12,500,000 warrants, raising gross proceeds of $5 m...
Haoxi Health Technology Announces Extraordinary General Meeting for Governance and Capital Changes
Nov 12, 2025
Haoxi Health Technology Limited announced an extraordinary general meeting of shareholders scheduled to discuss significant proposals, including increasing the voting rights of Class B shares and expanding the authorized share capital. These chang...
Haoxi Health Technology Closes $1.2 Million Private Placement
Oct 24, 2025
Haoxi Health Technology Limited, a company engaged in the health technology sector, announced the successful closing of a private placement on October 22, 2025. The company sold 5,217,391 Class A ordinary shares at $0.23 per share, raising $1.2 mi...
Haoxi Health Technology Secures $1.2 Million Through Private Placement
Oct 17, 2025
On October 13, 2025, Haoxi Health Technology Limited entered into a securities purchase agreement with non-U.S. investors to sell 5,217,391 Class A ordinary shares for approximately $1.2 million. The proceeds from this private placement will be us...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.